Unity Biotechnology, Inc.
NASDAQ:UBX
1.26 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 1.902 | 0 | 0 | 0 | -0.236 | 0 | 0.236 | 0 | 4.784 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 105.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.382 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0.221 | 0.227 | 0.231 | 0.308 | 0.314 | 0.329 | 0.409 | 0.535 | 0.609 | 0.627 | 4.784 | 0.708 | 0.744 | 0.757 | 65.809 | 0 | 0 | 0 | 52.75 | 17.777 | 18.468 | 16.505 | 16.33 | 14.353 | 15.198 | 13.025 | 11.591 | 9.599 | 9.213 | 6.97 |
| Gross Profit
| 0 | -0.221 | -0.227 | 1.671 | -0.308 | -0.314 | -0.329 | -0.645 | -0.535 | -0.373 | -0.627 | 0 | -0.708 | -0.744 | -0.757 | -65.809 | 0 | 0 | 0 | 52.75 | -17.777 | -18.468 | -16.505 | -16.33 | -14.353 | -15.198 | -13.025 | -10.209 | -9.599 | -9.213 | -6.97 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0.879 | 0 | 0 | 0 | 2.733 | 0 | -1.581 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.387 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 2.787 | 5.463 | 3.821 | 3.271 | 4.901 | 6.529 | 5.835 | 8.636 | 8.208 | 7.553 | 12.461 | 9.579 | 9.081 | 11.016 | 8.717 | 13.091 | 18.83 | 16.123 | 19.265 | 18.207 | 17.777 | 18.468 | 16.505 | 16.331 | 14.353 | 15.198 | 13.025 | 11.591 | 9.599 | 9.213 | 6.97 |
| General & Administrative Expenses
| 3.815 | 3.516 | 3.878 | 4.285 | 4.428 | 5.433 | 4.818 | 5.28 | 4.922 | 4.941 | 5.806 | 5.103 | 5.747 | 5.98 | 6.226 | 5.222 | 6.53 | 6.32 | 5.953 | 4.907 | 5.692 | 4.97 | 4.477 | 4.328 | 4.389 | 3.842 | 3.457 | 2.577 | 2.484 | 2.485 | 2.07 |
| Selling & Marketing Expenses
| 0 | 0.979 | 0.173 | 0.09 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 3.815 | 4.495 | 4.051 | 4.375 | 4.428 | 5.433 | 4.818 | 5.28 | 4.922 | 4.941 | 5.806 | 5.103 | 5.747 | 5.98 | 6.226 | 5.222 | 6.53 | 6.32 | 5.953 | 4.907 | 5.692 | 4.97 | 4.477 | 4.328 | 4.389 | 3.842 | 3.457 | 2.577 | 2.484 | 2.485 | 2.07 |
| Other Expenses
| 0 | -0.061 | -0.08 | -1.119 | 5.602 | -0.069 | -0.065 | -0.066 | -0.041 | -0.043 | 0.131 | 0.013 | -0.85 | -0.072 | -0.074 | -0.114 | -2.637 | 4.342 | -1.409 | 4.436 | -0.112 | -0.103 | -0.036 | -0.175 | -0.037 | -0.03 | -0.003 | -0.078 | -0.015 | -0.008 | -0.002 |
| Operating Expenses
| 6.602 | 9.958 | 7.872 | 7.646 | 14.931 | 11.962 | 10.653 | 13.916 | 13.13 | 12.494 | 18.267 | 14.682 | 14.828 | 16.996 | 14.943 | 18.313 | 25.36 | 22.443 | 25.218 | 23.114 | 23.469 | 23.438 | 20.982 | 20.659 | 18.742 | 19.04 | 16.482 | 14.168 | 12.083 | 11.698 | 9.04 |
| Operating Income
| -6.602 | -10.179 | -8.099 | -7.877 | -14.931 | -11.962 | -10.653 | -13.916 | -13.13 | -12.258 | -18.267 | -9.898 | -14.828 | -16.996 | -14.943 | -18.783 | -24.642 | -23.349 | -27.156 | -23.09 | -22.354 | -24.47 | -19.737 | -22.808 | -19.377 | -20.798 | -16.482 | -12.786 | -12.083 | -11.698 | -9.04 |
| Operating Income Ratio
| 0 | 0 | 0 | -4.141 | 0 | 0 | 0 | 58.966 | 0 | -51.941 | 0 | -2.069 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.219 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9.252 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.121 | 4.9 | 2.309 | 3.538 | -0.358 | -0.069 | -0.212 | -0.252 | -0.578 | -0.879 | -0.648 | 0.013 | -0.85 | -0.072 | -0.074 | -0.584 | -1.919 | 3.436 | -3.347 | 4.46 | 1.003 | -1.135 | 1.209 | -2.324 | -0.672 | -1.788 | -0.003 | -0.078 | -0.015 | -0.008 | -0.002 |
| Income Before Tax
| -6.481 | -5.279 | -5.79 | -4.339 | -15.289 | -12.205 | -10.865 | -14.168 | -13.708 | -13.137 | -18.915 | -10.693 | -16.45 | -17.826 | -15.756 | -19.587 | -27.552 | -18.667 | -28.038 | -18.027 | -21.71 | -23.673 | -18.767 | -21.917 | -18.346 | -20.002 | -16.133 | -12.543 | -11.75 | -11.428 | -8.934 |
| Income Before Tax Ratio
| 0 | 0 | 0 | -2.281 | 0 | 0 | 0 | 60.034 | 0 | -55.665 | 0 | -2.235 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.171 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9.076 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0.184 | -1.816 | -0.308 | 0.91 | 1.214 | -0.409 | 0.578 | 0.879 | 0.648 | -9.946 | -0.058 | 0.712 | 0.701 | -0.132 | -2.138 | 0.566 | 1.411 | -1.396 | -1.871 | 0.132 | -2.251 | 0.487 | -0.433 | 0.932 | -0.854 | -0.321 | -0.348 | -0.278 | -0.108 |
| Net Income
| -6.481 | -5.279 | -5.79 | -4.339 | -15.289 | -12.205 | -12.079 | -13.759 | -14.286 | -14.016 | -19.563 | -10.693 | -16.45 | -17.826 | -15.756 | -19.587 | -27.552 | -18.667 | -28.038 | -18.027 | -21.71 | -23.673 | -18.767 | -21.917 | -18.346 | -20.002 | -16.133 | -12.543 | -11.75 | -11.428 | -8.934 |
| Net Income Ratio
| 0 | 0 | 0 | -2.281 | 0 | 0 | 0 | 58.301 | 0 | -59.39 | 0 | -2.235 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.171 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9.076 | 0 | 0 | 0 |
| EPS
| -0.38 | -0.31 | -0.34 | -0.28 | -1.05 | -0.85 | -0.84 | -0.97 | -1.42 | -2.02 | -2.9 | -1.82 | -2.97 | -3.25 | -2.91 | -3.68 | -5.25 | -3.76 | -5.9 | -3.92 | -5.05 | -5.58 | -4.45 | -5.32 | -4.47 | -7.61 | -3.85 | -2.99 | -34.18 | -36.23 | -29.01 |
| EPS Diluted
| -0.38 | -0.31 | -0.34 | -0.28 | -1.05 | -0.85 | -0.84 | -0.97 | -1.42 | -2.02 | -2.9 | -1.82 | -2.97 | -3.25 | -2.91 | -3.68 | -5.25 | -3.76 | -5.9 | -3.92 | -5.05 | -5.58 | -4.45 | -5.32 | -4.47 | -7.61 | -3.85 | -2.99 | -34.18 | -36.23 | -29.01 |
| EBITDA
| -6.602 | -9.958 | -7.872 | -7.646 | -14.931 | -10.912 | -9.863 | -13.178 | -12.307 | -11.634 | -17.48 | -9.867 | -14.95 | -16.298 | -14.224 | -18.324 | -26.947 | -20.626 | -22.377 | -23.138 | -23.946 | -21.763 | -21.59 | -18.51 | -17.546 | -16.761 | -16.482 | -12.318 | -11.635 | -11.404 | -8.946 |
| EBITDA Ratio
| 0 | 0 | 0 | -4.02 | 0 | 0 | 0 | 55.839 | 0 | -49.297 | 0 | -2.063 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.219 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -8.913 | 0 | 0 | 0 |